Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of CB-03-01 1% cream in facial acne vulgaris
2015-002623-26Phase 3Completed
- Sponsor
- Cassiopea S.p.A.
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris comparing CB-03-01 1% cream with Vehicle cream (2 arms). Primary endpoint: Investigator's Global Assessment treatment success. Started Oct 2015; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2015-002623-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002623-26.